Highly purified, small dense splenic B cells from unstimulated mice showed increased expression ofclass II major histocompatibility complex (MHC) antigens and enhanced viability when cultured with affinity-purified recombinant interleukin 10 (HIA0), compared with B cells cultured in medium alone. These responses were blocked by a monoclonal antibody (mAb) specific for 11,10, but not by an isotype-matched control antibody. IL10 did not upregulate the expression of Fce receptors (CD23) or class I MHC antigens on small dense B cells or induce their replication as monitored by [3H]thymidine incorporation. While these B cell-stimulatory properties of IWO are also mediated by ID4, the two cytokines appear to act independently in these assays ; anti-IL10 antibodies blocked 1140 but not I14-mediated B cell viability enhancement, and vice versa. Similarly, since IIr4 upregulates CD23 on small dense B cells, the inability of IIr10 to do so argues against its acting via endogenously generated 114. Finally, IIA0 did not upregulate class II MHC antigens on B cells from X chromosome-linked immunodeficiency (XID) mice, while the same cells showed normal upregulation of class II antigens in response to 11.4. This report also extends our understanding of the relationship between IIA0 and the highly homologous Epstein-Barr virus (EBV)-encoded Barn HI fragment C rightward reading frame no. 1 (BCRFI) protein. It has previously been shown that BCRFI protein exhibits the cytokine synthesis inhibitory activity of IL10. This report indicates that BCRFI protein also enhances in vitro B cell viability, but does not upregulate class II MHC antigens on B cells. One explanation for these data is that 111,10 contains at least two functional epitopes, only one ofwhich has been conserved by EBV
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In this report, we show that 11,10 is also a novel B cell stimulatory factor, exerting at least two effects on small dense splenic B cells from unstimulated mice, namely upregulation of their class II MHC antigens and enhancement of their in vitro viability. X chromosome-linked immunodeficiency (XID) B cells are unresponsive to the class II inducing activity of IWO, suggesting a possible role for this cytokine in the immunodeficiency of these animals.
Materials and Methods
Mice. 8-12-wk-old female BALE/cByJ, DBA/2J, and CBA/J mice were obtained from The Jackson Laboratory (Bar Harbor, ME). The XID gene-bearing (CBA/N x DBA/2J) male and their normal female littermates were bred at the DNAX animal facility (DNAX Research Institute ofMolecular and Cellular Biology, Palo Alto, CA) from breeding pairs obtained from The Jackson Laboratory.
Anticytokine Antibodies. Hybridoma celllines producing rat IgM anti-IIA0 antibody (SXCI) (10) or an irrelevant rat IgM isotype control designatedJ5/D were expanded in serum-free medium, and the accumulated antibody was purified to a single band on a Coomassie blue-stained SDS-PAGE gel by two sequential 50% ammonium sulfate precipitates. Both antibodies were used at 10-50 jug/ml. Anti-1164 antibody (11B11) (11) and an IgG1 isotype control (GL113) were used at 10 hg/ml .
Cytokines. Mouse rI1610 was expressed in Escherichia coli and a$mity purified using the SXCI anti-11610 antibody (Castle, B. E., W Dang, R. Kastelein, and M. Howard, manuscript in preparation). Alternatively, mouse rI1r10(8), human rII1610 (12) , and BCRFI (9) were expressed in COS7 cells. Mock supernatants from COS7 cells transfected with no cDNA or irrelevant cDNA were used as negative controls. Natural 11610 derived from Con A-stimulated D10 Th cells was purified as described elsewhere (4) and generously provided by M. W Bond (DNAX). For both 11,10 and BCRFI, a unit of activity was defined as the amount of protein per milliliter that produced 50% of saturating activity in the cytokine synthesis inhibitory assay (4). Murine rM4 was expressed inE. colt as described byvan Kimmenade et al. (13) and was affinity purified as described elsewhere (14) . A unit of IIA activity was defined as the amount of 1164 per milliliter that produced 50% of saturating activity in the HT-2 cell proliferation assay (5).
B CellPreparation and Culture Small dense B cells from unstimulated mouse spleens were purified as described previously (15) . Briefly, spleen cells were teased into complete RPMI (cRPMI) containing 5% FCS (J.R. Scientific, Woodland, CA), 5 x 10-5 M 2-ME (Polysciences, Inc., Warrington, PA), 100 U/ml penicillin and 100 fag/ml streptomycin (Irvine Scientific, Santa Ana, CA), 2 mM glutamine (J.R. Scientific), and 25 mM Hepes buffer (Irvine Scientific) . RBC were lysed using 0.83% ammonium chloride, pH 7.4. In some experiments adherent cells were removed by incubating cells on petri dishes (Falcon Labware, Oxnard, CA) at 2 x 107 cells/ml, 10 ml/dish at 37°C for 1 h. T cells were subsequently removed using two successive treatments ofanti-mouse Thy-1.2 mAb (New England Nuclear, Boston, MA) and anti-L3T4 antibody (RL172.4 hybridoma, a gift from Dr. H. R. MacDonald, Ludwig Institute, Epalinges, Switzerland) for 20 min at 4°C, followed by complement (1:10 dilution of LowTox-Rabbit complement; Cedarlane Laboratory Ontario, Canada) for 30 min at 37°C. Small dense B cells were then isolated by density centrifugation using a discontinuous gradient composed of 75, 65, and 50% Percoll (Pharmacia Fine Chemicals, Uppsala, Sweden) at 2,500 x g for 25 min, at 4°C. Cells collected from the interface between 65 and 75% Percoll solutions were shown to be small dense B cells by several criteria (15, 16) and used in all subsequent experiments. Small B cells were cultured with various cytokines at 1-2 x 105 cells/well in 100101 cRPMI in 96-well flat-bottomed culture plates (3072; Falcon Labware) .
Immunofluorescence Determination of Surface Markers. Cultured B cells were harvested from microtiter plates, washed, then incubated at 1-2 x 105 cells/well for 30 min at 4°C with one of the following antibodies : biotinylated anti-I-A' (mouse IgG2a) at 2.5 ,ug/ml, biotinylated anti-H-2Kk (mouse IgG2a) at 2.5,ug/ml, biotinylated anti-huHLADR (mouse IgG2a) at 5 Kg/ml, or bio-
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Interleukin 10, a Novel B Cell Stimulatory Factor tinylated anti-rat tc chain (MAR 18.5, mouse IgG2a) at 5 I~g/ml, biotinylated anti-CD23 antibody (B3B4, rat IgG2a) at 5 wg/ml. 
Results
ILIO Upregulates Expression of Class II MHC Antigens on Small Dense B Cells. Highly purified small dense B cells from unstimulated BALB/c mouse spleens were cultured for 20-24 h either with various dilutions of affinity-purified rI1r10 expressed in E. coli, 100 U/ml affinity-purified rIlr4 as a positive control, or medium alone. Fig. l A shows that both 11,4 and a saturating dose (200 U/ml) of IIr10 caused substantial upregulation of B cell class II MHC antigen expression compared with B cells cultured in medium alone. B cells cultured under the same three conditions showed no difference in background staining using any of several biotinylated isotypematched negative control antibodies [e.g., anti-huHLADR, anti-H-2Kk, and MAR 18.5 (anti-rat K chain)] or after preincubation of the cells with anti-Fc receptor antibody (2.4G2) (data not shown) . These data indicate that II*10 does not increase nonspecific binding to B cells. Identical results of increased class II antigen expression were obtained using rI1r10 expressed in COS7. cells or highly purified natural M10 produced by activated D10 Th cells (data not shown) . IIr10--induced upregulation of class II antigen expression could be totally inhibited by anti-IIA0 mAb (SXCI) but not by an irrelevant isotype-matched control antibody (J5/D) (Fig. 1  B) . The amount ofmurine IIr10 required for optimal induction of class II MHC antigens on B cells was comparable with that needed for optimal suppression of cytokine synthesis by Thl cells ; -10--100 U/ml produced an optimal response in each assay. Affinity-purified rIlrl0 did not upregulate expression of class I MHC antigens or CD23 on small dense B cells (Fig. 2) . In fact, a small but detectable decrease in class I MHC antigen expression was observed after culture of B cells with IIAO (Fig . 2) .
IMO Does Not Upregulate Class II Antigen Expression on XID B Cells. While B cells from several normal strains of mice (e .g., BALB/cByj, and DBA/2J) responded to IL10 by upregulating class II MHC antigen expression, small dense splenic B cells from the immunodeficient XID mouse seemed incapable of this response . As shown in Fig. 3 , class II antigen expression on XID splenic B cells from CBA/N x DBA/2 male mice was upregulated after IL4 stimulation, but was unaltered after culture with IL10. In contrast, the normal control population of CBA/N x DBA/2 female mouse B cells showed significant upregulation ofclass II MHC antigen expression after either HA or IIAO stimulation (Fig. 3) .
IMO Enhances In Vitro Viability of Small Dense B Cells. Highly purified small dense B cells from unstimulated BALB/c 1627 Go et al . mouse spleens were cultured for various times with 30 U/ml highly purified natural 1140 from activated D10 cells, rIIA at 100 U/ml as a positive control, or medium alone. Viability was evaluated by trypan blue exclusion throughout a 4-d culture period (Fig. 4 A) . Alternatively, small B cells were cultured with various dilutions of COS7 cell-expressed mouse rIL10 (ranging from 150 to 0.15 U/ml), affinity-purified rIL4, or mock transfection supernatant from COS7 cells. Viability was measured by MTT assay at 3 d of culture (Fig. 4 B) . Both assays showed that coculture with IWO produced a marked enhancement of B cell viability. Identical results of enhanced mouse B cell viability were obtained using affinitypurified rIL10 expressed in E. coli (data not shown) . The level of 11,10-enhanced B cell viability was comparable with that obtained when B cells were cultured with IL4 (Fig. 4 ). Antibodies to IWO or IL4 blocked the enhanced B cell viability induced by each specific cytokine, but not by the other cytokine (Fig. 5) , suggesting that both cytokines acted independently in this assay. No additive or synergistic effect was observed when IIA0 and IIA were both added to the B cell cultures (data not shown) . While IIA0 enhanced the viability of small dense B cells, it did not induce their proliferation as evaluated by [3 H]thymidine incorporation (Fig. 6) . Similarly, 11,10 did not affect B cell proliferation induced by the polyclonal B cell activator, LPS (Fig. 6) . Eject of BCRFI Protein on Small Dense B Cells. As mentioned above, the sequence of IIA0 is highly homologous to that of an EBV open reading frame designated BCRFI (8) . Furthermore, IIr10 and BCRFI protein share the property of suppressing cytokine synthesis by activated Th1 cells (4, 9) . We therefore tested whether BCRFI protein also resembled IL10 in terms of its effects on small dense B cells. BCRFI protein expressed in COS7 cells caused a marked enhancement of the in vitro viability of small dense murine B cells (Fig. 7) . The level of viability enhancement was comparable with that induced by human rIIr10, although both of these stimuli were less effective than mouse 1140 in enhancing viability of mouse B cells (Fig. 7) . It is not surprising that at a functional level BCRFI is more closely related to human I1r10 than to mouse 11710, since BCRFI and human IL10 are both evolved to act on human cells and BCRFI shows a higher degree of homology to human IIr10 than to mouse IIA0 (12) . The results shown in Fig . 7 indicate that comparable amounts of each stimulus were effective at enhancing B cell viability. The maximal responses were obtained with 50 U/ml mouse IIA0, human IMO, or BCRFI, with units in each case referring to their respective activities in the murine cytokine synthesis inhibition assay (4) . In contrast, quantities of BCRFI protein varying from 25 to 250 U/ml did not significantly alter B cell class II antigen expression when compared with B cells cultured in COS7 mock supernatants or medium alone (Fig. 8 C) . Both mouse and human IWO within that concentration range were capable of maximal upregulation of B cell class II antigen expression (Fig. 8, A and B) . Thus, BCRFI appeared capable of mediating only one of the two B cell stimulatory properties of IIA0 described in this report . This conclusion is supported by results obtained in multiple experiments, using several preparations of BBCRFI . ated by IL4 (16, (19) (20) (21) (22) This study focuses on the ability of ID10 to directly stimulate small dense B cells. Separate studies have previously identified three factors capable of directly stimulating small dense B cells: IL4 (19, 20) , BCAF (27) , and TRF2 (28) . The latter two factors have not been purified to date and so their possible identity with 1140 cannot be excluded . Indeed, BCAF resembles IL10, in terms of inducing class II MHC antigens, but not CD23 on small dense B cells (27) , and TRF2 has been shown to be inactive on XID B cells (28) . While other properties would appear to distinguish these factors from IIL10, e.g., their ability to induce cell division and/or Ig secretion by resting B cells, it must be recognized that in the absence of purification or cloning, such responses may reflect synergisms between multiple biologically active molecules .
This study also extends our understanding of the mechanisms that regulate class II antigen expression on APC, with IIrl0 joining a group ofcytokines that were previously shown to regulate class II expression on different cell types (19, 20, (29) (30) (31) ) . An interesting picture concerning the interaction of Th cells and APC is beginning to emerge from these collective studies. IFN-y, a specific product of Thl cells (5), upregulates class II antigens on macrophages (30-32), but not on B cells (33) and suppresses IIA-induced class II upregulation on B cells (33, 34) . Conversely, IL10 and/or IIA, specific products of Th2 cells (4, 5), upregulate class II antigens on B cells (19, 20 ; this study) with little or no such effect on IFN-y-activated macrophages (reference 20; Fiorentino, D. F., A. Zlotnik, P. Vieira, T R. Mosmann, M. Howard, K. W Moore, and A. O'Garra, manuscript submitted for publication), and suppress production of IFN-y (4), a major activator of macrophage antigen-presenting function (30, 31) . Thus, it would appear that a product of Thl cells favors antigen presentation by macrophages, and products of Th2 cells favor antigen presentation by B cells . Whether these preferences correspond to a role for macrophages versus B cells in determining the nature of the helper T cell response generated in an immune response remains to be established .
Our data also provide further information concerning the relationship between the mammalian cytokine ID10 and the EBVencoded BCRFI protein. Both 1140 and BCRFI suppress cytokine production by Thl cells (9) . Our experiments suggest that both proteins enhance in vitro viability ofsmall dense B cells, but only ID10 upregulates class II MHC antigens on B cells. One explanation for these data is that BCRFI protein induces signals at a lower efficiency than 1140, with this efficiency being sufficient to trigger the thresholds of the CSIF and B cell viability enhancement assays, but insufficient to trigger the class II antigen-inducing effects. An alternative theory is that IIA0 contains at least two functional epitopes, one of which-mediates CSIF activity and enhancement of B cell viability, and the other which induces class II MHC antigens on B cells. The data obtained with BCRFI protein would be explained if only the first of these functional epitopes has been captured by EBV . This latter proposal oftwo functional epitopes is supported by separate studies that indicate that wide concentration ranges ofBCRFIencoded protein fail to mediate two other activities of 11,10, specifically growth costimulation of mature and immature murine thymocytes (35) , and ofmast cells (12) . Ifthe theory of two functional epitopes is correct, it is interesting that the two IL10 properties captured by the EBV protein, i.e., suppression of Thl-specific cytokines such as IFN-y and enhancement of B cell viability, are the properties most likely to enhance viral survival in the host, since EBV grows in B cells, and IFN-y is a major host defense against EBV transformation of B cells (36, 37) . 
